| Reaction Details |
|---|
 | Report a problem with these data |
| Target | N-lysine methyltransferase SMYD2 |
|---|
| Ligand | BDBM378802 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | SMYD2 Biochemical Assay |
|---|
| IC50 | 3.90±n/a nM |
|---|
| Citation |  Foley, MA; Kuntz, KW; Mills, JE; Mitchell, LH; Munchhof, MJ; Harvey, DM Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer US Patent US10266526 Publication Date 4/23/2019 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| N-lysine methyltransferase SMYD2 |
|---|
| Name: | N-lysine methyltransferase SMYD2 |
|---|
| Synonyms: | HSKM-B | Histone methyltransferase SMYD2 | KMT3C | Lysine N-methyltransferase 3C | N-lysine methyltransferase SMYD2 | SET and MYND domain-containing protein 2 | SET and MYND domain-containing protein 2 (SMYD2) | SMYD2 | SMYD2_HUMAN |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 49689.57 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q9NRG4 |
|---|
| Residue: | 433 |
|---|
| Sequence: | MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKE
GLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHP
ERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVN
CNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSY
IDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARN
VIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGAL
QYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDH
PYISEIKQEIESH
|
|
|
|---|
| BDBM378802 |
|---|
| n/a |
|---|
| Name | BDBM378802 |
|---|
| Synonyms: | N-(1-((1-(4-chlorobenzyl)-1H-pyrazol-4-yl)methyl)azetidin-3-yl)-1-cyclopropyl-1H-1,2,3-triazole-4-carboxamide | US10266526, Compound 985 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C20H22ClN7O |
|---|
| Mol. Mass. | 411.888 |
|---|
| SMILES | Clc1ccc(Cn2cc(CN3CC(C3)NC(=O)c3cn(nn3)C3CC3)cn2)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
